Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Donor KIR genotype based outcome prediction after allogeneic stem cell transplantation: no land in sight.
Schetelig J, Baldauf H, Heidenreich F, Hoogenboom JD, Spellman SR, Kulagin A, Schroeder T, Sengeloev H, Dreger P, Forcade E, Vydra J, Wagner-Drouet EM, Choi G, Paneesha S, Miranda NAA, Tanase A, de Wreede LC, Lange V, Schmidt AH, Sauter J, Fein JA, Bolon YT, He M, Marsh SGE, Gadalla SM, Paczesny S, Ruggeri A, Chabannon C, Fleischhauer K. Schetelig J, et al. Among authors: vydra j. Front Immunol. 2024 Apr 2;15:1350470. doi: 10.3389/fimmu.2024.1350470. eCollection 2024. Front Immunol. 2024. PMID: 38629074 Free PMC article.
Hematopoietic Stem Cell Transplantation From Haploidentical Donors in Aplasia After Cladribine/Cytarabine Chemotherapy for Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome.
Vydra J, Válková V, Čemusová B, Kolář M, Nováková L, Soukup P, Šálek C, Vraná M, Pytlík R, Lesný P, Vítek A, Cetkovský P, Marková M. Vydra J, et al. Clin Lymphoma Myeloma Leuk. 2019 Jun;19(6):365-371. doi: 10.1016/j.clml.2019.02.005. Epub 2019 Feb 20. Clin Lymphoma Myeloma Leuk. 2019. PMID: 30905537
WT1 Gene Expression in Peripheral Blood Before and After Allogeneic Stem Cell Transplantation is a Clinically Relevant Prognostic Marker in AML - A Single-center 14-year Experience.
Valkova V, Vydra J, Markova M, Cerovska E, Vrana M, Marinov I, Cechova H, Cetkovsky P, Vitek A, Salek C. Valkova V, et al. Among authors: vydra j. Clin Lymphoma Myeloma Leuk. 2021 Feb;21(2):e145-e151. doi: 10.1016/j.clml.2020.09.008. Epub 2020 Oct 12. Clin Lymphoma Myeloma Leuk. 2021. PMID: 33160932
Trends in allogeneic haematopoietic cell transplantation for myelofibrosis in Europe between 1995 and 2018: a CMWP of EBMT retrospective analysis.
McLornan D, Eikema DJ, Czerw T, Kröger N, Koster L, Reinhardt HC, Angelucci E, Robin M, Bornhäuser M, Passweg J, Clark A, Vydra J, Blau IE, Niittyvuopio R, Platzbecker U, Cornelissen JJ, Chevallier P, Srour M, Stamatovic D, Martinez-Lopez J, de Wreede L, Hayden P, Hernández-Boluda JC, Yakoub-Agha I. McLornan D, et al. Among authors: vydra j. Bone Marrow Transplant. 2021 Sep;56(9):2160-2172. doi: 10.1038/s41409-021-01305-x. Epub 2021 Apr 28. Bone Marrow Transplant. 2021. PMID: 33911203
Non-Mutated Nucleophosmin 1 Is Recognized by the CD8+ T Lymphocytes of an AML Patient after the Transplantation of Hematopoietic Stem Cells from an HLA-Haploidentical Donor.
Nemeckova S, Alexova-Zurkova K, Hainz P, Krystofova J, Mackova J, Roubalova K, Stastna-Markova M, Vrana M, Vydra J. Nemeckova S, et al. Among authors: vydra j. Curr Oncol. 2022 Apr 20;29(5):2928-2934. doi: 10.3390/curroncol29050239. Curr Oncol. 2022. PMID: 35621629 Free PMC article.
Human leukocyte antigen-haploidentical transplantation for relapsed/refractory acute myeloid leukemia: Better leukemia-free survival with bone marrow than with peripheral blood stem cells in patients ≥55 years of age.
Baron F, Labopin M, Tischer J, Ciceri F, Raiola AM, Blaise D, Sica S, Vydra J, Fanin R, Stölzel F, Busca A, Diez-Martin JL, Koc Y, Nagler A, Mohty M. Baron F, et al. Among authors: vydra j. Am J Hematol. 2022 Aug;97(8):1065-1074. doi: 10.1002/ajh.26627. Epub 2022 Jun 24. Am J Hematol. 2022. PMID: 35696192 Free article.
Comparison of Outcomes after Unrelated Double-Unit Cord Blood and Haploidentical Peripheral Blood Stem Cell Transplantation in Adults with Acute Myelogenous Leukemia: A Study on Behalf of Eurocord and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Ruggeri A, Galimard JE, Labopin M, Rafii H, Blaise D, Ciceri F, Diez-Martin JL, Cornelissen J, Chevallier P, Sanchez-Guijo F, Nicholson E, Castagna L, Forcade E, Kuball J, Rovira M, Koc Y, Pavlu J, Gulbas Z, Vydra J, Baron F, Sanz J, Spyridonidis A, Savani B, Gluckman E, Nagler A, Mohty M. Ruggeri A, et al. Among authors: vydra j. Transplant Cell Ther. 2022 Oct;28(10):710.e1-710.e10. doi: 10.1016/j.jtct.2022.07.006. Epub 2022 Jul 11. Transplant Cell Ther. 2022. PMID: 35830930 Free article.
Comparison of HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute myeloid leukemia.
Baron F, Labopin M, Tischer J, Ciceri F, Raiola AM, Blaise D, Sica S, Vydra J, Fanin R, Diez-Martin JL, Bulabois CE, Stölzel F, Busca A, Jindra P, Koc Y, Chevallier P, Forcade E, Rösler W, Passweg J, Kulagin A, Carella AM, Simand C, Bazarbachi A, Pioltelli P, Nagler A, Mohty M. Baron F, et al. Among authors: vydra j. Bone Marrow Transplant. 2022 Nov;57(11):1657-1663. doi: 10.1038/s41409-022-01781-9. Epub 2022 Aug 17. Bone Marrow Transplant. 2022. PMID: 35978005 Free article.
Impact of Cytogenetic Risk on Outcomes of Non-T-Cell-Depleted Haploidentical Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia.
Nagler A, Labopin M, Dholaria B, Ciceri F, Fraccaroli A, Blaise D, Fanin R, Bruno B, Forcade E, Vydra J, Chevallier P, Bulabois CE, Jindra P, Bornhäuser M, Canaani J, Sanz J, Savani BN, Spyridonidis A, Giebel S, Brissot E, Bazarbachi A, Esteve J, Mohty M. Nagler A, et al. Among authors: vydra j. Transplant Cell Ther. 2022 Nov;28(11):773.e1-773.e8. doi: 10.1016/j.jtct.2022.08.018. Epub 2022 Aug 27. Transplant Cell Ther. 2022. PMID: 36031079 Free article.
59 results